Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura--a case report and literature review.
In acute coronary syndromes, GPIIb/IIIa platelet inhibitors have demonstrated a reduction in recurrent myocardial ischemia. Conversely, one might expect that enhancing platelet activity in patients in acute coronary syndromes would have the opposite effect. We report a patient with idiopathic thrombocytopenic purpura (ITP) that had recurrent myocardial ischemia associated with administration of intravenous immunogloblin (IVIG). Literature is reviewed.
Crouch
Eron D
ED
Community Internal Medicine, Scott & White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, Temple, Texas 76508, USA.
Watson
Linley E
LE
D000368:Aged; D017023:Coronary Angiography; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D017202:Myocardial Ischemia / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous